Competent and Reliable Scientific Evidence
Competent and reliable scientific evidence is the strict legal threshold enforced by the Federal Trade Commission (ftc) that advertisers must meet to substantiate health, wellness, and efficacy claims before disseminating an advertisement.
Definition and Requirements
The FTC defines this standard as:
“Tests, analyses, research, studies, or other evidence based on the expertise of professionals in the relevant area, that have been conducted and evaluated in an objective manner by persons qualified to do so, using procedures generally accepted in the profession to yield accurate and reliable results.”
In practice, this standard requires:
- Randomized Controlled Trials (RCTs): The FTC views well-designed, randomized, double-blind, placebo-controlled human clinical testing as the most reliable form of evidence.
- Clinical Meaningfulness: It is not enough for study results to be mathematically or statistically significant in a lab setting; the benefits must translate to a noticeable, clinically meaningful effect for the consumer.
- Quality and Quantity: The research must be sufficient in both quality and quantity, evaluating the totality of the evidence rather than cherry-picking isolated favorable studies.
Application to Functional Beverages
As the beverage industry pivots toward functional premiumization using adaptogens and nootropics, this standard has become a critical hurdle. Brands must navigate the structure-function-vs-drug-claims boundary, ensuring they only make permissible wellness claims (e.g., “supports stress response”) rather than illegal disease claims.
However, the industry faces a severe clinical-substantiation-gap. While historical or in vitro data may exist for raw botanical ingredients, there is a lack of well-powered RCTs proving their efficacy in specific beverage formats and doses.
The “Clinically Proven” Trap
Using definitive language like “clinically proven” without a perfectly aligned, highly powered RCT is considered a “litigation magnet.” Brands that fail to meet the competent and reliable scientific evidence standard—such as the supplement brand prevagen—invite severe FTC Consent Orders, FDA Warning Letters, and class-action civil lawsuits. Marketers are strongly advised to avoid definitive terms when the underlying science is evolving or lacks format-specific human trials.